A research letter in JAMA Health Forum found significant improvements in consistent postpartum coverage in the United States during the COVID-19 pandemic, driven by increases in consistent Medicaid and lower rates of Medicaid loss for postpartum mothers.
“Studies have shown that the postpartum period is typically a time of heightened insurance instability, primarily because individuals [with] pregnancy-related Medicaid coverage lose eligibility after 60 days postpartum,” said principal investigator Erica Eliason, PhD, postdoctoral research fellow in health services, policy and practice at Brown University School of Public Health in Providence, Rhode Island. “As a result, individuals must qualify for parental Medicaid to maintain Medicaid coverage past this period, which has more restrictive income eligibility, or find alternative insurance options.”
The change in insurance eligibility leads to high uninsurance in the postpartum period for those who had pregnancy-related Medicaid coverage, according to Eliason. “However, to promote insurance access during the COVID-19 public health emergency, there was a Medicaid policy change that froze disenrollment, which meant that anyone who was going to lose Medicaid eligibility no longer did.”
The pandemic Medicaid policy inspired the authors to examine changes in postpartum Medicaid eligibility, “which has been of recent policy interest at the state and national level,” Eliason told Contemporary OB/GYN®.
The investigators culled data from the 2019 to 2021 Current Population Survey, Annual Social and Economic Supplement. (Among the 4,448 postpartum respondents, the shift from insured to uninsured decreased by 1.3%, from 3.1% in 2019 (before the pandemic) to 1.8% during the pandemic in 2021. Results indicated no other significant coverage changes overall.1
In 2019, 88.2% of postpartum respondents with Medicaid in the prior year had consistent Medicaid coverage, while 10.3% lost coverage and 1.6% changed to private coverage.
In 2021, consistent Medicaid coverage increased by 6.8% and Medicaid-uninsured churn decreased by 6.6%, representing a 64% decline from 2019.
In 2019, 97.1% of all postpartum respondents with private coverage during the prior year also maintained consistent private coverage, while 1.4% had private-Medicaid churn and 1.3% lost coverage.
Compared to 2019, private-Medicaid churn increased by 1.5% in 2021.
“The findings were largely what we expected,” Eliason said. “Although the pandemic policy was not specific to promoting postpartum Medicaid, we anticipated there would be improvements in postpartum Medicaid, because so many were losing Medicaid coverage in this period prior to the policy change.”
Eliason noted that the increase in continuous postpartum coverage should provide enhanced access to care postpartum, “but this policy change occurred during the pandemic, which other research has shown led to reduced health care use, so it might not have achieved the same improvements in postpartum care access that would have occurred if not for the pandemic,” she said.
“Individuals may not have known that they remained insured and as a result may not have seen an improvement in access to postpartum care,” Eliason said.
The pandemic Medicaid policy change continues to be extended, but is currently set to expire in July 2022. “When this policy is lifted, postpartum individuals whose pregnancy-related Medicaid coverage was going to stop after 60 days postpartum will lose this Medicaid coverage,” Eliason said, “and we “could see large numbers of people who had stable Medicaid during the pandemic suddenly uninsured.”
Reference
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More